Envestnet Portfolio Solutions
GILD icon

Envestnet Portfolio Solutions’s Gilead Sciences GILD Stock Holding History

Envestnet Portfolio Solutions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Sell
86,812
-1,643
-2% -$216K 0.05% 206
2026
Q1 		$12.3M Sell
88,455
-17,153
-16% -$2.4M 0.07% 168
2025
Q4 		$13M Buy
105,608
+5,500
+5% +$668K 0.05% 201
2025
Q3 		$11.1M Buy
100,108
+47,457
+90% +$5.39M 0.04% 205
2025
Q2 		$5.84M Sell
52,651
-17,147
-25% -$1.82M 0.02% 325
2025
Q1 		$7.82M Sell
69,798
-41,974
-38% -$4.33M 0.03% 271
2024
Q4 		$10.3M Buy
111,772
+6,815
+6% +$614K 0.03% 241
2024
Q3 		$8.8M Sell
104,957
-1,254
-1% -$95.7K 0.03% 275
2024
Q2 		$7.29M Sell
106,211
-6,532
-6% -$436K 0.03% 287
2024
Q1 		$8.26M Buy
112,743
+27,211
+32% +$2.09M 0.03% 269
2023
Q4 		$6.93M Sell
85,532
-1,525
-2% -$119K 0.03% 263
2023
Q3 		$6.52M Buy
+87,057
New +$6.7M 0.03% 250

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Portfolio Solutions's GILD Position: Q2 2026 in Review

Envestnet Portfolio Solutions reduced its Gilead Sciences (GILD) stake by 1.9% in Q2 2026, selling an estimated $216K and leaving 86,812 shares worth $11M. The position accounts for 0.05% of the portfolio, ranked #206.

Envestnet Portfolio Solutions first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $13M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Envestnet Portfolio Solutions held 86,812 shares of Gilead Sciences worth $11M as of Q2 2026.
  • Envestnet Portfolio Solutions sold 1,643 Gilead Sciences shares in Q2 2026, an estimated $216K.
  • Gilead Sciences made up 0.05% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #206 holding.
  • Envestnet Portfolio Solutions first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Gilead Sciences position peaked at $13M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.